Nicholas Valiante

Nicholas Valiante, PhD, is head of research at Caperna, LLC. After receiving a PH.D. in immunology from the University of Pennsylvania and a post-doctoral fellowship at Stanford University, Nick joined Chiron Corporation (later Novartis) as a senior scientist in 1997. Throughout various corporate reorganizations, mergers and acquisitions, he moved up through the research and development organization to become Global Head of Immunology and Immunotherapy with responsibility for >150 scientists worldwide and he won the Novartis Leading Scientist Award in 2012. In September 2015 Nick joined Moderna Therapeutics, a biotech startup in Cambridge, MA, where he and his team are bringing mRNA-based personalized cancer vaccines to clinical trials this year.